Associate Professor, Neurology, University of Washington School of Medicine
Neurology
Dr. Maciej Mrugala, MD
|
|
Give Review
Doctor Maciej Mrugala, MD practices Neurology. He studied medicine at Medical University of Warsaw. He received 1 awards: "Regional Top Doctor". Maciej Mrugala is a published MD as well. He has 32 publications published. The latest was: Reply to comment on: 'Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach'. He is registered with Medicare.
Publications
- Addendum to 'A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET'.
- Central Nervous System Cancers, Version 1.2015.
- A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
- Central Nervous system cancers, version 2.2014.
- Clinical Practice Experience with NovoTTF-100A™ System for Glioblastoma: the Patient Registry Dataset (PRiDe).
- Invasion and proliferation kinetics in enhancing Gliomas predict IDH1 mutation status.
- A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory Meningiomas.
- Retrospective analysis of the tolerability and activity of lacosamide in patients with Brain tumors: clinical article.
- Advances and challenges in the treatment of glioblastoma: a clinician's perspective.
- Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric.
- Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.
- Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.
- From patient-specific mathematical neuro-oncology to precision medicine.
- Temozolomide: Expanding its role in Brain cancer.
- Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach.
- Rhythmic multiunit neural activity in slices of hamster suprachiasmatic nucleus reflect prior photoperiod.
- Outside the box-novel therapeutic strategies for glioblastoma.
- Central Nervous system cancers.
- Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.
- Genetic determinants of hearing loss associated with vestibular Schwannomas.
- Insights into the biology of primary central Nervous system lymphoma.
- High-dose methotrexate for elderly patients with primary CNS Lymphoma.
- Mechanisms of Disease: temozolomide and glioblastoma--look to the future.
- Intracranial Meningiomas: an overview of diagnosis and treatment.
- AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
- Peripheral and cranial nerve sheath tumors.
- Therapy for recurrent malignant glioma in adults.
- Neurologic complications of hematologic neoplasms.
- Transplanted clonal neural stem-like cells respond to remote photic stimulation following incorporation within the suprachiasmatic nucleus.
- Reply to comment on: 'Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach'.
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Autonomic Dysreflexia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Massachusetts -
Medical University of Warsaw
Hospital
-
University of Washington Medical Center
Drug Facts
| NPI NUMBER | 1376533620 | |
| NPPES Provider LastName | MRUGALA | |
| NPPES Provider FirstName | MACIEJ | |
| NPPES Provider ZIPCode | 981956465 | |
| NPPES Provider State | WA | |
| Specialty Description | Neurology | |
| Total Claim Count | 328.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 3.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376533620 |
| Last Name Of The Provider | MRUGALA |
| First Name Of The Provider | MACIEJ |
| View All |
Similar Doctors
|
|
Matthew K. Preston
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce R. Ransom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda M. Ojemann, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kyle J. Steinman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas P. Poolos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Russell, MD |
|
|
Dr. William E. Berg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam S. Reynolds, MD |
|
|
Dr. Juan A. Piantino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonard A. Scheele, MD |